That can't be known for sure, both the one you mention and the one on the safety of CBD for the treatment of acne, are "poster only" sessions, but it could be possible that both relate to BOT's trials.
The GM is on Friday the 11th and there should be news in the week after, which is 'coincidentally' (?) when the conference starts.
In any case the publication of the Orlando's IID schedule points to the fact that there are only TWO presentations (among more then 1400) dealing with cannabidiol -CBD- and we know which company is pioneering its formulation for the treatment of acne and atopic dermatitis!
https://iid2018.org/wp-content/uplo...T-STATUS-NOTIFICATION-FINAL-by-FINAL-ID-1.pdf
Big News Coming for the Patient, page-127
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.005(1.54%) |
Mkt cap ! $581.5M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.0¢ | 32.0¢ | $1.058M | 3.280M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 147750 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 632850 | 6 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |